REATA PHARMACEUTICALS INC (RETA) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-10
11:32 am
Sale
2022-02-0913GReata Pharmaceuticals, Inc.
RETA
Invesco Ltd.
IVZ
2,280,409
7.200%
-1,157,169decrease
(-33.66%)
Filing
History
2022-02-10
08:32 am
Purchase
2021-12-3113GReata Pharmaceuticals, Inc.
RETA
The Vanguard Group2,557,673
8.130%
237,642increase
(+10.24%)
Filing
History
2022-02-04
4:12 pm
Purchase
2021-12-3113GReata Pharmaceuticals, Inc.
RETA
BlackRock Inc.
BLK
2,114,050
6.700%
737,966increase
(+53.63%)
Filing
History
2022-02-04
09:22 am
Sale
2021-12-3113GReata Pharmaceuticals, Inc.
RETA
Wellington Management Group LLP4,252,977
13.510%
-92,747decrease
(-2.13%)
Filing
History
2021-09-10
10:22 am
Purchase
2021-09-1013GReata Pharmaceuticals, Inc.
RETA
Invesco Ltd.
IVZ
3,437,578
10.900%
1,658,103increase
(+93.18%)
Filing
History
2021-02-12
6:48 pm
Purchase
2021-02-1213GReata Pharmaceuticals, Inc.
RETA
Invesco Ltd.
IVZ
1,779,475
5.700%
1,779,475increase
(New Position)
Filing
History
2021-02-10
11:47 am
Purchase
2020-12-3113GReata Pharmaceuticals, Inc.
RETA
The Vanguard Group2,320,031
7.470%
153,145increase
(+7.07%)
Filing
History
2021-02-04
09:57 am
Purchase
2020-12-3113GReata Pharmaceuticals, Inc.
RETA
Wellington Management Group LLP4,345,724
13.990%
1,324,800increase
(+43.85%)
Filing
History
Goto Prev, 0, 1